leisure time -WSS

leisure time

author：fashion 2025-10-02 12:31:55 - browse：7371

glum Benjamin — health insurance coverage from STAT — Adobe

Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The problem with charging patients to message their doctors

WSS

Doctor of U.S. President Joe Biden says he is fit for duty

Precocious puberty in girls comes with mental health risks

Using force crossed my mind when examining a defiant young patient

Amylyx ALS drug failure raises questions and concerns

Headspace, Meta partner to launch VR meditation app for Quest

Headspace, Meta partner to launch VR meditation app for Quest

leisure time

leisure time

focus

Heart attack and stroke risk calculators need revising

Childhood vaccination ad campaign launches in the U.K.

Tori Bowie and the unacceptable rates of Black maternal death

https://cbu01.alicdn.com/img/ibank/2016/546/439/3362934645_157890472.220x220xz.jpg

Anesthesiologist group: stop taking Ozempic before surgery

Color Health wants to make cancer screenings convenient

Apple is now the first public company to be valued at $3 trillion

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Activists slam private health insurers over coverage restrictions

Elisabeth Bik tackles the widespread issue of research misconduct

explore

NEJM study measures Covid brain fog, impact on IQ

First medicine developed to treat MASH expected to be approved soon

Medicare isn't yet testing food as medicine

'Vaccine

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Doctor of U.S. President Joe Biden says he is fit for duty

hotspot

focus

hotspot

focus